SCHEMBL7385502

SCHEMBL7385502

CC(C)(C)OC(=O)N(CCCO)Cc1cc(F)ccc1Br.CC(C)(C)OC(=O)OC(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 1/20 0.47
CA14 Q9ULX7 1/20 0.36
NR3C1 P04150 1/20 0.33
HTR2C P28335 2/20 0.33
SLC6A4 P31645 2/20 0.33
HTR2A P28223 1/20 0.33
RIPK1 Q13546 3/20 0.33
GRM2 Q14416 1/20 0.32
CPB2 Q96IY4 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
KDM4E B2RXH2 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
HSD17B10 Q99714 1/20 0.30
KCNQ4 P56696 1/20 0.30
KCNQ5 Q9NR82 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4715109 0.94 SSTR4 (0.52) SSTR4CA14NR3C1HTR2CSLC6A4
SCHEMBL4718059 0.81 SSTR4 (0.50) SSTR4CA14RIPK1HDAC1HSD17B10
SCHEMBL4719084 0.80 SSTR4 (0.46) SSTR4CA14HDAC1KDM4EALDH1A1
SCHEMBL4718013 0.77 SSTR4 (0.43) SSTR4CA14ALDH1A1HPGD
SCHEMBL25047728 0.77 SSTR4 (0.48) SSTR4CA14RIPK1GRM2HDAC1
SCHEMBL4715979 0.77 SSTR4 (0.43) SSTR4NR3C1HTR2CSLC6A4HTR2A
SCHEMBL4715976 0.77 SSTR4 (0.43) SSTR4NR3C1HTR2CSLC6A4HTR2A
SCHEMBL12715855 0.76 GRM2 (0.43) SSTR4NR3C1HTR2CSLC6A4HTR2A
SCHEMBL23105683 0.75 RIPK1 (0.49) SSTR4NR3C1HTR2CSLC6A4HTR2A
SCHEMBL14762235 0.75 SSTR4 (0.52) SSTR4CA14HTR2CSLC6A4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1216230-A2 FUSED CYCLOHEPTANE AND FUSED AZACYCLOHEPTANE COMPOUNDS AND THEIR USE AS INTEGRIN RECEPTOR ANTAGONISTS Amgen Inc. (US) 2002-06-26 EP disclosed
WO-2001023357-A2 FUSED CYCLOHEPTANE AND FUSED AZACYCLOHEPTANE COMPOUNDS AND THEIR USE AS INTEGRIN RECEPTOR ANTAGONISTS AMGEN INC. (US) 2001-04-05 WO disclosed